Metastatic Colorectal Cancers Completed Phase 3 Trials for Panitumumab (DB01269)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01001377ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerTreatment
NCT00339183Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy AloneTreatment
NCT00364013PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine EfficacyTreatment
NCT01412957Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal CancerTreatment